F095 Skin and Systemic Malignancy
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The intersection between systemic malignancy is a rich, varied, and dynamic territory, familiarity with which is critical for the dermatologist. As “window to the soul,” the skin can reveal systemic malignancy via cutaneous metastases, genodermatoses, infections, or paraneoplastic dermatoses. Conversely, cancer therapeutics, including agents of complementary/alternative medicine, can induce significant cutaneous effects. Surgical therapeutics play a critical role in optimal management of cutaneous issues of systemic malignancy. These topics will be explored in this forum through discussion of patient cases with audience participation, aiming to enhance the attendee’s approach to detection, work-up, and care of patients with suspected skin signs of systemic malignancy, to better manage mucocutaneous effects of systemic therapy, and to optimally employ surgical tools in dermato-oncology. Mention of the future of the field, including the potential role of augmented intelligence will also be discussed. This forum is designed for both clinicians in practice and those in training.
LEARNING OBJECTIVES
Identify skin manifestations of systemic malignancy presenting as various paraneoplastic dermatoses, infections, genodermatoses, and skin metastases.
Recognize the spectrum of cutaneous effects (including drug reactions, cutaneous infections, etc) of therapeutics for systemic malignancy, including agents of alternative/complementary medicine, with mention of the potential future role of augmented intelligence in dermato-oncology.
Summarize optimal surgical approaches to dermato-oncologic issues.
SCHEDULE
10:30 PM
Introduction & Overview
Vincent Liu, MD, FAAD
10:35 PM
Paraneoplastic Dermatoses & Cutaneous Metastases
Vincent Liu, MD, FAAD
10:55 PM
Rashes and Other Mucocutaneous Effects of Cancer Therapy
Bernice Kwong, MD, FAAD
11:20 PM
Surgical Approach to Dermato-oncology
Nkanyezi Ngwenyama Ferguson, MD, FAAD
11:40 PM
Skin Infections and Systemic Malignancy
Jina Chung, MD, FAAD
12:05 AM
Complementary/Alternative Medicine, Augmented Intelligence, and Skin & Systemic Malignancy
Peter A. Lio, MD, FAAD
SPEAKERS
Jina Chung, MD, FAAD
Nkanyezi Ngwenyama Ferguson, MD, FAAD
Bernice Kwong, MD, FAAD
Peter A. Lio, MD, FAAD
Vincent Liu, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Jina Chung, MD, FAAD
No financial relationships exist with ineligible companies.
Nkanyezi Ngwenyama Ferguson, MD, FAAD
No financial relationships exist with ineligible companies.
Bernice Kwong, MD, FAAD
Happy 2nd Birthday, Inc – Consultant(Fees), Consultant(No Compensation Received); Novartis – Consultant(Fees); Novocure – Investigator(No Compensation Received); OncoDerm LLC – Consultant(No Compensation Received);
Peter A. Lio, MD, FAAD
AbbVie – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Almirall – Advisory Board(Fees), Speaker(Fees); Alphyn Biologics – Advisory Board(Honoraria); Amyris, Inc. – Consultant(Fees); AOBiome, LLC – Investigator(Grants/Research Funding); Apogee Therapeutics – Advisory Board(Fees); Arbonne – Advisory Board(Honoraria); Arcutis Biotherapeutics – Speaker(Fees); Arcutis, Inc. – Advisory Board(Fees); ASLAN Pharmaceuticals – Advisory Board(Fees); Bodewell – Advisory Board(Fees); Boston Skin Science LLC – Advisory Board(Stock); Bristol-Myers Squibb – Advisory Board(Fees); Burt's Bees – Consultant(Fees); Castle Biosciences – Advisory Board(Fees); Codex Labs – Advisory Board(Stock Options); Concerto Biosciences – Consultant(Stock Options); Dermavant Sciences – Advisory Board(Honoraria); Dermira – Consultant(Fees); DermVeda – Advisory Board(Stock Options); Eczema Foundation (Formerly La Fondation pour la Dermatite Atopique) – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees), Speaker(Fees); Galderma Laboratories, LP – Advisory Board(Fees); Galderma USA – Speaker(Honoraria); Hyphens Pharma – Speaker(Honoraria); Incyte Corporation – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Johnson & Johnson Consumer Products Company – Advisory Board(Honoraria); Kimberly Clark – Consultant(Fees); L'Oreal USA Inc. – Consultant(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker(Honoraria); LearnHealth/LearnSkin – Stockholder(Stock Options); LEO Laboratories Ltd (LEO Pharma) – Consultant(Fees); Leo Pharma Inc – Speaker(Fees); Lipidor – Consultant(Fees); Medable – Stockholder(Stock Options); Merck – Advisory Board(Honoraria); Micreos Human Health B.V. – Advisory Board(Stock Options); Modernizing Medicine – Advisory Board(No Compensation Received), Stockholder(Stock Options); MyOR Diagnostics Ltd – Consultant(Fees), Speaker(Honoraria); National Eczema Association – Advisory Board(No Compensation Received), Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); ParentMD – Speaker(Patent royalties or other compensation for Intellectual Property Rights); Pelthos Therapeutics – Advisory Board(Fees); Pfizer Inc. – Speaker(Honoraria); Pierre Fabre Dermatologie – Speaker(Honoraria); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Sanofi US Services – Advisory Board(Honoraria); Sibel Health – Consultant(Fees); Skinfix, Inc. – Consultant(Fees); Sonica LLC – Consultant(Fees); SOTERI SKIN, INC. – Advisory Board(Stock Options); Suneco Technologies – Advisory Board(Stock Options); Syncere Skin Systems – Advisory Board(Stock Options); Theraplex – Consultant(Fees), Other(Patent royalties or other compensation for Intellectual Property Rights); Thimble Health – Advisory Board(Stock Options); UCB – Advisory Board(Honoraria); Unilever – Consultant(Fees); Verdant Scientific, Inc. – Advisory Board(Stock Options); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria), Speaker(Fees); YobeeCare Inc. – Advisory Board(Stock Options);
Vincent Liu, MD, FAAD
Springer Publishing – Other(Patent royalties or other compensation for Intellectual Property Rights); WoltersKluwer Health – Other(Patent royalties or other compensation for Intellectual Property Rights);